Split History
ETFs Holding VBIV »    VBIV Historical Stock Prices »
Video: What is a Stock Split?

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
VBI Vaccines is a biopharmaceutical company. Co. develops vaccine candidates that mimic the natural presentation of viruses. Co.'s pipeline is comprised of vaccine and immunotherapeutic candidates developed by virus-like particle technologies to target two disease areas, infectious disease and oncology. Co.'s prophylactic candidates are 3-antigen Vaccine for the indication of Hepatitis B (HBV), VBI-1501 for the indication of Cytomegalovirus (CMV), VBI-2901 for the indication of Pan-coronavirus, and VBI-2902 for the indication of COVID-19. Co.'s therapeutic candidates are VBI-2601 for the indication of HBV and VBI-1901 for the indication of Glioblastoma plus other CMV-Associated Cancers. According to our VBIV split history records, VBI Vaccines has had 1 split.
VBIV split history picture
VBI Vaccines (VBIV) has 1 split in our VBIV split history database. The split for VBIV took place on July 29, 2014. This was a 1 for 5 reverse split, meaning for each 5 shares of VBIV owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 200 share position following the split.

When a company such as VBI Vaccines conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.

Looking at the VBIV split history from start to finish, an original position size of 1000 shares would have turned into 200 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into VBI Vaccines shares, starting with a $10,000 purchase of VBIV, presented on a split-history-adjusted basis factoring in the complete VBIV split history. VBIV split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 10/04/2012
End date: 09/30/2022
Start price/share: $3.90
End price/share: $0.71
Dividends collected/share: $0.00
Total return: -81.79%
Average Annual Total Return: -15.67%
Starting investment: $10,000.00
Ending investment: $1,820.65
Years: 9.99
Date Ratio
07/29/20141 for 5
VBIV is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

VERO Split History
VICL Split History
VIR Split History
VIVE Split History
VIVO Split History
VLRX Split History
VRTX Split History
VSCP Split History
VVUS Split History
VXRT Split History

Also explore: VBIV shares outstanding history

Email EnvelopeFree VBIV Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

American Virtual Cloud Technologies, Inc. (AVCT)
Avenue Therapeutics, Inc. (ATXI)
Annaly Capital Management, Inc. (NLY)
CohBar, Inc. (CWBR)
TOP Ships Inc. (TOPS)
Sonnet BioTherapeutics Holdings, Inc. (SONN)
Nabriva Therapeutics plc (NBRV)
NeuroBo Pharmaceuticals, Inc. (NRBO)
First Wave BioPharma, Inc. (FWBI)
Palatin Technologies, Inc. (PTIN)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

VBIV Insider Buying

VBIV Split History | www.SplitHistory.com | Copyright © 2013 - 2022, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.